Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

NCT02594761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Hercules
BIOLOGICAL: Herceptin EU
BIOLOGICAL: Herceptin US

Sponsor

Mylan Pharmaceuticals Inc

Collaborators

[object Object]